An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice
Clinical trial NCT02552940 · COMPLETED
Trial details
- NCT number
- NCT02552940
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-10-31
- Primary completion
- 2017-10-23
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.